Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
When the Price of (SAVA) Talks, People Listen | news.google.com • |
Mirae Asset Global Investments Co. Ltd. Purchases 1418 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) | news.google.com • |
SAVA June 7th Options Begin Trading | news.google.com • |
Cassava Sciences (NASDAQ:SAVA) Trading Up 4.6% | news.google.com • |
Raymond James Financial Services Advisors Inc. Decreases Holdings in Cassava Sciences, Inc. (NASDAQ:SAVA) | news.google.com • |
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference | globenewswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-06 | 2024-03 | -0.51 | N/A | N/A | N/A |
2024-02-28 | 2023-12 | -0.4 | -0.5 | -0.1 | -25.00% |
2023-11-07 | 2023-09 | -0.9 | -0.61 | 0.29 | 32.22% |
2023-08-03 | 2023-06 | -0.58 | -0.63 | -0.05 | -8.62% |
2023-05-01 | 2023-03 | -0.56 | -0.58 | -0.02 | -3.57% |
2023-02-28 | 2022-12 | -0.58 | -0.47 | 0.11 | 18.97% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-07 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-07-05 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-10 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-08 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-05 | HC Wainwright & Co. | Upgrade | Buy | |
2023-01-23 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2018-10-02 | ARMISTICE CAPITAL L.L.C. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2023-05-23 | BARBIER REMI | Chief Executive Officer | 0.00 | Conversion of Exercise of derivative security |
2024-04-22 | BARRY RICHARD J | Director | 0.00 | Conversion of Exercise of derivative security |
2022-10-02 | FRIEDMANN NADAV | Officer and Director | 80.05K | Conversion of Exercise of derivative security |
2023-04-30 | GUSSIN ROBERT Z | Director | 10.62K | Conversion of Exercise of derivative security |
2024-04-17 | KUPIEC JAMES WILLIAM | Officer | 4.00K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 2.75M | 67.35M | 6.54% |
2023-06-29 | Vanguard Group Inc | 2.25M | 55.16M | 5.36% |
2023-06-29 | State Street Corporation | 952.09K | 23.35M | 2.27% |
2023-06-29 | Geode Capital Management, LLC | 803.31K | 19.70M | 1.91% |
2023-06-29 | Gallacher Capital Management LLC | 583.29K | 14.30M | 1.39% |
2023-06-29 | Northern Trust Corporation | 370.64K | 9.09M | 0.88% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.23M | 30.21M | 2.94% |
2023-08-30 | iShares Russell 2000 ETF | 908.42K | 19.05M | 2.16% |
2023-06-29 | Vanguard Extended Market Index Fund | 542.35K | 13.30M | 1.29% |
2023-07-30 | Fidelity Small Cap Index Fund | 353.09K | 7.76M | 0.84% |
2023-08-30 | iShares Russell 2000 Growth ETF | 333.17K | 6.99M | 0.79% |
2023-05-30 | Fidelity Extended Market Index Fund | 202.34K | 4.60M | 0.48% |
Dividend | Date |
---|---|
0.75 | 2012-12-13 |
2 | 2010-12-13 |
Split | Date |
---|---|
1 : 7 | 2017-05-10 |
-
$SAVA WILL END WEEK BELOW $40 Just confirmed. Thanks short initiated !!!
-
$SAVA estimated $35 - $40 @ close Friday based soon to expiry options
-
Can SAVA sustain $2B valuation, even with a Phase 3 continuation? What data are they providing to show anything , except that they had “successful” FDA meeting? There is no drug pipeline, might be too early peaked out on their value prop. Look at G1TX, they got FDA approval for their drug, still half SAVA price. Believing in something is good but do DD too.
-
Keep rising like moon
-
-
-
I saw one ask people to buy in at $90. Little dip and pullback , lol. You lost 50% if you listen to these bullshits
-
Can we still trust this sava
-
To all shorts here, you are right that fundamentals is lacking here but that is not the point here. This stock got shorted from 128, greed works on both side too you know. Cover now or you’ll see your gain dissipates too. Be satisfied with what you have now.
-
-
-
What happened?? From sky to burrows in a matter of few eye blinks!!!
-
ALYI Welcomes Elon Musk And Tesla To Texas – Now How About Joining Us In Africa Too?
December 11, 2020 Stock Day Media 592 Views ALYI, elonmusk, Elonmusknews, tesla
PR NewswireDALLAS, Dec. 11, 2020
DALLAS, Dec. 11, 2020 /PRNewswire/ — Alternet Systems, Inc. (USOTC: ALYI), an electric vehicle innovation company headquartered in Dallas, Texas, today welcomed Elon Musk and Tesla to Texas.
-
ANXL is heading for another rise, come make some $$
-
-
Bought 2 shares of $SAVA today
-
Waiting for the massive drop tomorrow $SAVA
-
-
Really? The moment i sell the share it rises further
-
This is so overbought look at the rsi
-
When the Price of (SAVA) Talks, People Listen
news.google.com • -
SAVA June 7th Options Begin Trading
news.google.com • -
Cassava Sciences (NASDAQ:SAVA) Trading Up 4.6%
news.google.com • -
Exit Now! 3 Biotech Stocks to Sell in February 2024
investorplace.com • -
3 small-cap biotechs with potential breakthroughs in 2024
marketbeat.com • -
3 Biotech Stocks to Sell in January Before They Crash and Burn
investorplace.com • -
Portfolio Protection: 7 Risky Stocks to Drop Right Now
investorplace.com • -
New SAVAW Warrants Are Trading After Cassava Sciences' Distribution
investorplace.com • -
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
investorplace.com • -
Why Cassava Sciences Stock Soared Today
fool.com • -
Alzheimer's Disease Drug Development: Another Lost Year
seekingalpha.com • -
7 High-Risk, High-Reward Stocks for the Extreme Contrarian
investorplace.com • -
1 Big Red Flag to Fear When a Stock Is Down
fool.com • -
Cassava Sciences: My Bullish Take On Biomarkers And CTAD Data
seekingalpha.com • -
7 Stocks That Are Heading for a Train Wreck
investorplace.com • -
SAVA Stock Continues to Plunge on Misconduct Allegations
investorplace.com • -
SAVA Stock Alert: Cassava Sciences Addresses Leaked Report
investorplace.com • -
Cassava Sciences slumps after leaked report claims 'egregious misconduct' over Alzheimer's drug
proactiveinvestors.com • -
Cassava Sciences slumps after leak claims “egregious misconduct”
proactiveinvestors.co.uk • -
Cassava Sciences to Present at the Jefferies Biotech CNS/Neuro Summit in NY
globenewswire.com • -
The 7 Best Meme Stocks to Buy Now: September 2023
investorplace.com • -
Cassava Sciences Invited to Present in Four Upcoming Investor Conferences
globenewswire.com • -
Week Of 08/28 Notable Insider Buys
seekingalpha.com • -
Week Of 08/21 Notable Insider Buys
seekingalpha.com • -
Insider Richard Barry Just Doubled Down on Cassava (SAVA) Stock
investorplace.com • -
Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now
investorplace.com • -
Cassava Sciences: Positive Data Continues To Derisk Ongoing Phase 3 Trials
seekingalpha.com • -
Cassava Sciences (SAVA) Stock Drops Despite Positive Trial Results
investorplace.com • -
Cassava Sciences to Present at the Jefferies Global Healthcare Conference
globenewswire.com • -
Why Is Cassava Sciences (SAVA) Stock Up 15% Today?
investorplace.com • -
Buy Cassava Sciences For Imminent Data Readout
seekingalpha.com • -
Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference
globenewswire.com • -
Strong Small-Cap Insider Buys: Q1 2023
seekingalpha.com • -
3 Short-Squeeze Stocks to Keep on Your Radar
investorplace.com • -
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
investorplace.com • -
Cassava Sciences Stock Undervalued with Its $124 Price Target?
marketbeat.com • -
Cassava Sciences' Data Once Again Misunderstood
seekingalpha.com • -
Why Is Cassava Sciences (SAVA) Stock Down 20% Today?
investorplace.com • -
Is a Short Squeeze Coming in Cassava Sciences (SAVA) Stock?
investorplace.com • -
6 Favorite Biotech Bets For 2023
forbes.com • -
Why Is Cassava Sciences (SAVA) Stock Up 10% Today?
investorplace.com • -
Cassava Sciences Stock's Bull Signal Has Never Been Wrong
schaeffersresearch.com • -
7 Stocks Rattled by Corporate Scandals and Shenanigans in 2022
investorplace.com • -
Why Is Cassava Sciences (SAVA) Stock Up Today?
investorplace.com • -
Cassava Sciences Has a Big Warning for SAVA Stock Short Sellers
investorplace.com • -
Trading Ideas On The Upcoming CTAD 2022 Conference
seekingalpha.com • -
Why Is Cassava Sciences (SAVA) Stock Down 10% Today?
investorplace.com • -
SAVA Stock Alert: Cassava Sciences Extends Trial
investorplace.com • -
How High Can SAVA Stock Go Once the Controversy Clears?
investorplace.com • -
Cassava Sciences Stock: Huge Returns Or Catastrophic Losses
seekingalpha.com • -
Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
investorplace.com • -
5 Investors Betting Big on Cassava (SAVA) Stock
investorplace.com • -
Cassava: High Risk Speculative Play With Enormous Potential
seekingalpha.com • -
The Huge Reason Cassava Sciences (SAVA) Stock Is Rocketing Higher
investorplace.com • -
The SEC Has Officially Cleared Cassava Sciences
seekingalpha.com • -
What Is Going on With Cassava (SAVA) Stock Today?
investorplace.com • -
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
globenewswire.com • -
Cassava Sciences Looks As Good Of A Purchase As Ever
seekingalpha.com • -
Insider Richard Barry Is Betting Big on Cassava (SAVA) Stock
investorplace.com • -
Why Is Cassava Sciences (SAVA) Stock Up 20% Today?
investorplace.com • -
Cassava's Simufilam And Acetylcholinesterase Inhibitors: Similar Results
seekingalpha.com • -
10 Stocks to Sell Before They Die
investorplace.com • -
Cassava (SAVA) Stock Falls 30% on Report of Criminal Probe
investorplace.com • -
7 Meme Stocks Trading at a Massive Discount Right Now
investorplace.com • -
Cassava Sciences And Alzheimer's Disease: A Precipitious Path
seekingalpha.com • -
Stay Far Away From Cassava Sciences Amid Data Integrity Criticisms
investorplace.com • -
Take Full Advantage of Weakness in Cassava Sciences Stock
investorplace.com • -
Cassava Sciences Is a Worthwhile Bet to Consider
investorplace.com • -
The Crowd Has Wisely Soured on Cassava Sciences Stock
investorplace.com • -
Fresh Crop of Concerns Surrounding Alzheimer's Drug Sinks SAVA
schaeffersresearch.com •